Featured Editorial
-
How To Choose Fit-For-Purpose Tech With The Modified Delphi Method
8/19/2024
When it comes to selecting a new clinical trial technology, consultant Aurea Flores, Ph.D. suggests stakeholders and end users explore options and make recommendations based on a modified version of the Delphi Method.
-
Early Planning Trumps eCOA Bells & Whistles
8/16/2024
Julie Dietrich is a huge advocate for detailed documentation and early planning when it comes to successfully implementing eCOA systems. A good old-fashioned focus group couldn’t hurt either, she says.
-
Why We Need Technology Consolidation In Clinical Trials
8/16/2024
As more and more trial designs incorporate technologies that generate an immense amount of data, data managers struggle to continuously interconnect disparate systems and standardize data. All of this fuels the need for technology consolidation.
-
Is Blockchain The Solution To Derisking Unreliable Clinical Trial Data?
8/16/2024
Technological advances have provided fertile ground for scientific fraud, but blockchain just may be the key to ensuring a transparent, trusted, and certified process for collecting, managing, and analyzing clinical trial data.
-
A Quick & Easy Guide To Site-Facing Clinical Trial Technologies
8/15/2024
Consultant Aurea Flores, Ph.D. summarizes some of the clinical trial technologies used by clinical research sites, their capabilities, and how sponsors and sites might best evaluate their use in clinical research.
-
What Sites Need: Trial Technology Integration, Support, And Evaluation
8/14/2024
In part two of this series, SCRS Vice President of Site Engagement Jimmy Bechtel discusses how site technology should be chosen, customized, and eventually evaluated for success.
-
Some Truths You Can't Avoid About eCOA
8/13/2024
The advantages of eCOA systems often overshadow some of the potential challenges they could create. Robert Goldman expounds on some of his first-hand experiences over the years with ePRO and eCOA implementations that went awry.
-
What Sites Need: Trial Technology Selection, Buy-In, And Implementation
8/13/2024
SCRS Vice President of Site Engagement Jimmy Bechtel poses questions and offers helpful tips aimed at helping sponsors understand site technology needs in this two-part series, with part one focused on technology selection and implementation.
-
Managing Risk In New And Emerging Trial Technology Trends
7/31/2024
As technology advances, the risk that comes with integrating them into clinical trials rises. Beazley U.S. Life Sciences Underwriter Brendan Tarte discusses how to manage risk with tech like wearables, DHTs, AI/ML, and more.
-
Correct But Misleading: AI Hallucinations In Complex Decision-Making
7/11/2024
Managing risks associated with AI hallucinations requires "explainability," a process that identifies patterns or behaviors in AI models that are inconsistent with training data or logical expectations. Regulators are mandating transparency in AI models used for drug testing and development.